Related references
Note: Only part of the references are listed.The efficacy efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experience
Murat Albayrak et al.
TRANSFUSION AND APHERESIS SCIENCE (2019)
Oxidative burden in familial hypercholesterolemia
Hamid Mollazadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Pleiotropic effects of regular lipoprotein-apheresis
Helmut Sinzinger et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Long-term follow-up of circulating oxidative stress markers in patients undergoing lipoprotein apheresis by Direct Adsorption of Lipids (DALI)
Steffi Kopprasch et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Antioxidant defense system in familial hypercholesterolemia and the effects of lipoprotein apheresis
V. Blaha et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Current insights into the German Lipoprotein Apheresis Registry (GLAR) - Almost 5 years on
V. J. J. Schettler et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia
Jean-Philippe Drouin-Chartier et al.
CIRCULATION (2017)
Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis
Hata Hussein et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies
Vibha Rani et al.
LIFE SCIENCES (2016)
Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters - A comparison of two different apheresis techniques
Steffi Kopprasch et al.
ATHEROSCLEROSIS SUPPLEMENTS (2015)
Effects of different lipoprotein apheresis methods on serum protein levels
U. Julius et al.
ATHEROSCLEROSIS SUPPLEMENTS (2015)
Relation between oxidative stress and climacteric symptoms in early postmenopausal women
A. Cagnacci et al.
CLIMACTERIC (2015)
Familial Hypercholesterolemia-Epidemiology, Diagnosis, and Screening
Siddharth Singh et al.
CURRENT ATHEROSCLEROSIS REPORTS (2015)
Elevated Atherosclerosis-Related Gene Expression, Monocyte Activation and Microparticle-Release Are Related to Increased Lipoprotein-Associated Oxidative Stress in Familial Hypercholesterolemia
Morten Hjuler Nielsen et al.
PLOS ONE (2015)
Oxidative stress and cancer: An overview
Venus Sosa et al.
AGEING RESEARCH REVIEWS (2013)
The evidence-base for the efficacy of lipoprotein apheresis in combating cardiovascular disease
Gilbert R. Thompson
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases
Juan F. Aranda et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Oxidative Stress in Atherosclerosis Development: The Central Role of LDL and Oxidative Burst
Ilaria Peluso et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Cancer as a metabolic disease
Thomas N. Seyfried et al.
NUTRITION & METABOLISM (2010)
Recommendations for the use of LDL apheresis
G. R. Thompson
ATHEROSCLEROSIS (2008)
LDL-apheresis reduces P-selectin, CRP and fibrinogen - Possible important implications for improving atherosclerosis
Shuzo Kobayashi et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2006)
Effect of lipoprotein apheresis on oxidative stress and antioxidant status in familial hypercholesterolemic patients
E Kurtoglu et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2003)
C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis
PM Moriarty et al.
ATHEROSCLEROSIS (2001)